CRISPR Therapeutics AG
CRSP | NASDAQ
$51.40
-$2.86 (-5.27%)
At close: Oct 30, 2026, 3:59 PM ET
$51.75
+$0.35 (+0.68%)
Pre-market:
Nov 2, 2026, 9:23 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -11.46 | -7.65 | -8.04 | -11.59 | -8.96 | -7.53 | -9.01 | -16.72 | -16.81 | -25.25 | -32.27 | -10.15 | -10.59 | -6.73 | -4.86 | -7.43 | -7.38 | 15.02 | 15.19 | 21.12 | 28.65 | -21.53 |
PEG Ratio | 0.43 | 1.16 | -0.47 | 0.23 | -0.17 | -0.03 | 0.16 | 0.52 | -4.01 | 0.11 | 0.18 | -0.23 | -0.23 | 0.13 | 0.13 | 1.11 | -2.14 | 0.58 | 1.49 | -0.18 | -0.04 | 16.47 |
PS Ratio | 393.06 | 1.11K | 1.34K | 157.19 | 113.36 | 79.07 | 91.85 | 19.86 | 22.79 | 20.62 | 13.48 | n/a | 26.10 | 35.49 | 7.3K | 382.05 | 346.91 | 5.30 | 6.36 | 9.46 | 13.63 | 11.95K |
PB Ratio | 3.01 | 2.52 | 2.45 | 3.09 | 2.48 | 1.60 | 1.74 | 2.06 | 2.31 | 2.68 | 2.65 | 2.09 | 2.44 | 1.92 | 1.70 | 2.61 | 2.25 | 2.16 | 2.42 | 3.39 | 4.71 | 5.06 |
P/FCF Ratio | -10.95 | -11.39 | -13.63 | -19.52 | -13.01 | -9.50 | -23.25 | -20.94 | -36.35 | -33.48 | -18.49 | -12.32 | -12.27 | -9.45 | -5.98 | -10.01 | -9.12 | 11.68 | 12.70 | 18.33 | 24.44 | -29.53 |
P/OCF Ratio | -11 | -11.42 | -13.67 | -19.56 | -13.04 | -9.54 | -23.56 | -21.21 | -37.63 | -34.98 | -19.16 | -12.98 | -12.95 | -10.12 | -6.42 | -10.87 | -10.58 | 9.59 | 10.78 | 15.67 | 22.34 | -31.83 |
OCF/S Ratio | -1.89K | -7.47K | -10.71K | -9.52K | -12.77K | -6.24K | -142.95 | -17.76K | -18.49K | 21.78K | -48.04 | n/a | -190.35 | 8.80 | -1.89M | -111.93K | -89.85K | -75.98K | -667.01 | -24.72K | 89.65 | -49.83K |
Debt / Equity Ratio | 0.45 | 0.43 | 0.21 | 0.21 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.13 | 0.14 | 0.14 | 0.13 | 0.13 | 0.12 | 0.12 | 0.11 | 0.09 | 0.08 | 0.07 | 0.03 |
Quick Ratio | 17.85 | 17.96 | 13.25 | 16.22 | 16.61 | 15.64 | 22.07 | 21.64 | 15.73 | 17.81 | 17.54 | 15.83 | 14 | 13 | 15.30 | 12.81 | 17.57 | 19.88 | 20.17 | 26.18 | 26.23 | 22.05 |
Current Ratio | 17.85 | 17.96 | 13.25 | 16.22 | 16.61 | 15.64 | 22.07 | 21.64 | 15.73 | 17.81 | 17.54 | 15.83 | 14 | 13 | 15.30 | 12.81 | 17.57 | 19.88 | 20.17 | 26.18 | 26.23 | 22.05 |
Asset Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.09 | n/a | 0.03 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0.31 | 0 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -5.22% | -6.77% | -6.80% | -5.56% | -12.19% | -7.43% | -1.93% | -4.43% | -6.38% | -5.59% | 4.75% | -6.49% | -4.28% | -2.86% | -5.90% | -8.93% | -8.89% | -7.98% | -5.89% | -5.06% | 29.16% | -6.27% |
Return on Assets | -3.44% | -4.51% | -5.77% | -4.74% | -10.27% | -6.28% | -1.66% | -3.81% | -5.40% | -4.78% | 4.01% | -5.37% | -3.54% | -2.36% | -4.93% | -7.42% | -7.54% | -6.88% | -5.13% | -4.51% | 26.18% | -5.78% |
Return on Invested Capital | -4.53% | -4.99% | -7.28% | -6.16% | -6.85% | -7.19% | -2.97% | -5.04% | -6.79% | -6.02% | 3.25% | -6.65% | -4.58% | -3.05% | -5.67% | -8.21% | -7.79% | -7.03% | -5.51% | -4.68% | 26.94% | -6.07% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -337.80% | -3.35K% | -6.77K% | -7.18K% | -5.48K% | -6.55K% | 100% | -2.55K% | -10.92K% | -10.18K% | 90% | n/a | 36.23% | 57.81% | -113.62K% | -41.24K% | -21.37K% | -17.12K% | -945.96% | -6.73K% | 97.01% | -9.77K% |
Net Profit Margin | -895.33% | -8.43K% | -15.12K% | -11.97K% | -23.38K% | -15.72K% | -106.60% | -14.28K% | -24.45K% | -23.13K% | 44.67% | n/a | -111.06% | -53.06% | -1.84M% | -185.69K% | -117.62K% | -100.68K% | -1.1K% | -38.65K% | 84.34% | -56.02K% |
Pretax Profit Margin | -885.91% | -8.37K% | -15.05K% | -11.9K% | -23.24K% | -15.59K% | -104.60% | -14.13K% | -24.2K% | -22.99K% | 44.79% | n/a | -109.74% | -51.74% | -2M% | -186.3K% | -113.74K% | -98.66K% | -1.08K% | -38.83K% | 84.80% | -55.74K% |
Operating Profit Margin | -1.13K% | -8.93K% | -17.91K% | -14.85K% | -14.92K% | -17.16K% | -184.54% | -18.29K% | -29.26K% | -27.89K% | 34.79% | n/a | -136.03% | -64.49% | -2.19M% | -194.03K% | -115.99K% | -98.86K% | -1.13K% | -39.16K% | 84.72% | -56.7K% |
FCF Margin | -1.9K% | -7.5K% | -10.77K% | -9.53K% | -12.78K% | -6.26K% | -143.67% | -17.8K% | -18.62K% | 21.63K% | -48.41% | n/a | -195.43% | 5.74% | -1.99M% | -118.34K% | -95.94K% | -84.6K% | -738.20% | -35.98K% | 86.49% | -53.31K% |
EBITDA Margin | -1.09K% | -8.08K% | -14.39K% | -11.4K% | -22.72K% | -15.05K% | -90.77% | -13.34K% | -23.26K% | -22.03K% | 47.24% | n/a | -102.65% | -46.69% | -1.9M% | -180.96K% | -109.14K% | -95.26K% | -1.03K% | -37.21K% | 85.21% | -55.36K% |
Add to Watchlist
Select watchlists to add or remove CRSP